Showing results (11-20 of 83) with videos related to

Sort By:
Pageof 9
Biochimica Et Biophysica Acta|May 1, 2013
The HER2 amplicon in breast cancer: Topoisomerase IIA and beyondWilliam Jacot, Maryse Fiche, Khalil Zaman, et al.
Annales De Biologie Clinique|February 9, 2023
[Immuno-analytical characteristics of PSA and derived biomarkers (total PSA, free PSA, p2PSA)]Cédric Desbène, Mathieu Boissan, Sylvain Loric, et al.
Annales De Biologie Clinique|December 14, 2018
Relevance of total PSA and free PSA prescriptionsPierre-Jean Lamy, Jean-Paul Brouillet, Laurent Bermont, et al.
Plos One|January 17, 2025
Kidney and gallbladder stones and the risk of prostate cancer: Results from the EPICAP studyMelissa Sawaya, Emilie Cordina-Duverger, Pierre-Jean Lamy, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 12, 2026
Xpert® bladder Cancer monitor urine test for non-muscle-invasive bladder cancer surveillance: a prospective clinical trialMohamed Trabelssi, Pierre-Jean Lamy, Jean-Pierre Daures, et al.
Annales De Biologie Clinique|July 17, 2012
[Iron metabolism in breast cancer: knowledge and future]Anna Durigova, William Jacot, Stéphane Pouderoux, et al.
Oncotarget|October 24, 2018
Abdominal obesity and prostate cancer risk: epidemiological evidence from the EPICAP studyCéline Lavalette, Brigitte Trétarre, Xavier Rebillard, et al.
Oncotarget|May 29, 2018
Family history of breast cancer increases the risk of prostate cancer: results from the EPICAP studyPierre-Jean Lamy, Brigitte Trétarre, Xavier Rebillard, et al.
International Journal of Oncology|September 13, 2013
Cathepsin D stimulates the activities of secreted plasminogen activators in the breast cancer acidic environmentMarie Maynadier, Reza Farnoud, Pierre-Jean Lamy, et al.
Frontiers in Oncology|January 26, 2024
HE4 and CA-125 kinetics to predict outcome in patients with recurrent epithelial ovarian carcinoma: the META4 clinical trialMichel Fabbro, Pierre-Jean Lamy, Célia Touraine, et al.
Pageof 9